Haemato-oncology experts discuss managing the practicalities of CAR T-cell therapy in relapsed or refractory follicular lymphoma

touchIN CONVERSATION for touchONCOLOGY Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell therapy. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME. For further information visit our website: touchoncology.com/